Migrant Workers of Indonesia: Transmission Channels of SARS-CoV-2 Amidst COVID-19 Pandemic in Indonesia

Suteja, Richard Christian; Novianti, Putu Astri; Dewi, Kadek Ayu Candra; Widiyanti, Endang Sri; Wijayanti, Ida Ayu Sri; K, Cokorde Istri Yuliandari Krisnawardani; Purnamasidhi, Cokorda Agung Wahyu

doi:10.5455/ijmrcr.2020-05-197

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The rate of how COVID-19 pandemic had swept across the world at an unprecedented rate had resiliency within the healthcare system in all parts of the world, with no exception to critical care, being tested. During the early days of the pandemic, no prior extensive knowledge about how the virus operates poses as a major obstacle for critical care physicians to practice appropriate actions during critical care (Suteja et al, 2020). Even on phases of continuation, the fact that SARS-CoV-2 mutates in order to survive, which suggests a possible outbreak such as those in found in the alpha, beta, and delta variant, is unsettling.…”

Section: Introductionmentioning

confidence: 99%

The use of extracorporeal membrane oxygenation (ECMO) for critically-ill COVID-19 patient in clinical setting: A literature review

Purnamasidhi,

Suteja,

Utama

et al. 2023

RSD

View full text Add to dashboard Cite

The use of ECMO may help sustain extracorporeal life support in cases where regular less-invasive modalities failed to adequately assist the body in maintaining basic life mechanisms. Typically, VV-ECMO is used in life-threatening respiratory failure. However, experts must consider relative contraindications, answering the question: ‘Will the patient really benefit from this treatment, or will it only add emotional and economic burden, also exposing the patient to various risks of complications?’. The physiology of oxygenation within the lungs, tissues, and ECMO machine, is a modification of the basic principles of respiratory physiology. In typical VV-ECMO cannula insertion, drainage cannula is inserted via the right femoral vein percutaneously and is guided upwards through inferior vena cava with its tip 10 cm below cavoatrial junction while the reinjection cannula will be inserted through the intrajugular vein. This places the artificial lungs in series with the normal lungs rather than in a parallel form. The artificially-oxygenated blood was then returned and mixed with the native venous blood. It is important to measure maximum drainage flow to prevent shunting of the veins by setting the ECMO to the highest flow. Frequent complications include co-infection up to sepsis and coagulopathy up to complications following it. Therefore, it is always beneficial to acquire multidisciplinary judgement, particularly with hematologists, intensivists, and infectious disease specialists prior, during, and post-ECMO use.

show abstract

Section: Introductionmentioning

confidence: 99%

The use of extracorporeal membrane oxygenation (ECMO) for critically-ill COVID-19 patient in clinical setting: A literature review

Purnamasidhi,

Suteja,

Utama

et al. 2023

RSD

View full text Add to dashboard Cite

show abstract

“…In late December 2019, a pneumonia outbreak rose in a wet market in Hubei, Wuhan, China. (Suteja et al, 2020) This outbreak later spread rapidly through droplets or aerosols and on 11 March 2020, World Health Organization declared a COVID-19 pandemic situation caused by SARS-CoV-2 (Suteja et al, 2020;WHO, 2020). This virus has 85% similarity to its predecessor and is targeting Angiotensin-converting Enzyme 2 (ACE-2) that is overexpressed in lung and gastrointestinal (Majumder & Minko, 2021;Petrosillo et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

Molnupiravir: a novel efficacious antiviral candidate to COVID-19

Sumardika

Purnamasidhi

Darwinata

et al. 2021

RSD

View full text Add to dashboard Cite

An unknown pneumonia-like disease has emerged in Wuhan, China, in late 2019. It is later named as SARS-CoV-2 which cause COVID-19. This virus spreads easily due to high mobilization and its transmission through droplets or aerosol and fomite. The World Health Organization (WHO) then declared this disease as a global outbreak in March 2020. As the world faces the outbreak of SARS-CoV-2, many researchers race to find the most efficacious treatment for COVID-19. Until now, the most common treatments for COVID-19 were only symptomatic such as decongestant, corticosteroid, interleukin inhibitor, and existing antiviral. The researchers then develop a brand new antiviral that works efficiently to inhibit SARS-CoV-2 and might become prophylaxis. This disease is called Molnupiravir or EIDD-2801, a nucleotide analog which inhibits SARS-CoV-2 replication, resulting in damaged mRNA and lethal virions. Molnupiravir works to produce mutagenesis in RNA viruses and prevent the virus from spreading widely throughout the human body. However, this drug is still needed to undergo clinical trial phase three. In this article, we will discuss how Molnupiravir works and its efficacy compared to existing drugs. This review article aims to provide an update about novel efficacious antiviral for COVID-19, Molnupiravir.

show abstract

Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis

Suteja

Salim

Suryanov

et al. 2023

Transplant Immunology

View full text Add to dashboard Cite

Migrant Workers of Indonesia: Transmission Channels of SARS-CoV-2 Amidst COVID-19 Pandemic in Indonesia

Cited by 3 publications

References 0 publications

The use of extracorporeal membrane oxygenation (ECMO) for critically-ill COVID-19 patient in clinical setting: A literature review

The use of extracorporeal membrane oxygenation (ECMO) for critically-ill COVID-19 patient in clinical setting: A literature review

Molnupiravir: a novel efficacious antiviral candidate to COVID-19

Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis

Contact Info

Product

Resources

About